RNAC - Cartesian Therapeutics Inc
6.85
-0.030 -0.438%
Share volume: 180,236
Last Updated: 03-06-2026
Pharmaceutical Products/Pharmaceutical Preparations:
3.14%
PREVIOUS CLOSE
CHG
CHG%
$6.88
-0.03
0.00%
Summary score
42%
Profitability
49%
Dept financing
42%
Liquidity
58%
Performance
30%
Sector
Manufacturing
Industry
Pharmaceutical Products/Pharmaceutical Preparations
Long-term ratios 30-Sep-2021 - 30-Sep-2025
The data are presented for the financials results of the quarters of the last 4 years.
Return on equity
22.71%
Return on assets
-3.85%
Return on sales
-1028.62%
Return on invested capital
29.25%
Total debt ratio
85.75%
Debt ratio change over timeo
-1.43%
Current Ratio
6.41%
Quick Ratio
4.13%
Cash Position Ratio
5.96%
Short-term ratios 30-Sep-2024 - 30-Sep-2025
The data are presented for the financials results of the quarters of the last year.
Return on equity
0%
Return on assets
-4.34%
Return on sales
-2611.95%
Return on invested capital
0%
Total debt ratio
104.29%
Debt ratio change over timeo
0%
Current Ratio
11.44%
Quick Ratio
0%
Cash Position Ratio
11.19%
Last quarter ratios 30-Sep-2025
The data are presented for the financials results of the last quarter.
Return on equity
0%
Return on assets
-10.05%
Return on sales
-4660.62%
Return on invested capital
0%
Total debt ratio
109.62%
Debt ratio change over time
0%
Current Ratio
10.67%
Quick Ratio
0%
Cash Position Ratio
10.39%
Performance ratios (change over 4 years) 30-Sep-2021 - 30-Sep-2025
The data are presented for the change financials results of the quarter of the last 4 years.
Return on equity
-95.44%
Return on assets
-104.45%
Return on sales
-122.08%
Return on invested capital
-88.38%
Total debt ratio
-143.25%
Debt ratio change over time
-1.43%
Current Ratio
-4.42%
Quick Ratio
-3.27%
Cash Position Ratio
-3.83%
Compare in sector
The following table compares the individual analyzes for the other top 3 stocks within the same industry.
| Long-term ratios | RNAC | LLY | JNJ | ABBV |
|---|---|---|---|---|
| Return on equity | 22.71% | 13.23% | 9.84% | 26.17% |
| Return on assets | -3.85% | 4.59% | 3.2% | 1.81% |
| Return on sales | -1028.62% | 30.04% | 25.15% | 24.65% |
| Return on invested capital | 29.25% | 8.51% | 10.28% | 4.83% |
| Profitability | 47% | 70% | 57% | 60% |
| Total debt ratio | 85.75% | 80.7% | 59.39% | 93.28% |
| Debt ratio change over time | -1.43% | -16.59% | -73.52% | 21.11% |
| Dept financing | 23% | 22% | 16% | 50% |
| Current Ratio | 11.44% | 1.34% | 1.11% | 0.72% |
| Quick Ratio | 0% | 1.05% | 0.86% | 0.6% |
| Cash Position Ratio | 11.19% | 0.14% | 0.46% | 0.15% |
| Liquididy | 75% | 11% | 12% | 9% |
| Short-term ratios | RNAC | LLY | JNJ | ABBV |
|---|---|---|---|---|
| Return on equity | 0% | 0% | 0% | 0% |
| Return on assets | -4.34% | 5.82% | 4.08% | 0.78% |
| Return on sales | -2611.95% | 38.27% | 25.36% | 15.48% |
| Return on invested capital | 0% | 0% | 0% | 0% |
| Profitability | 50% | 50% | 34% | 13% |
| Total debt ratio | 104.29% | 81.38% | 59.57% | 99.65% |
| Debt ratio change over time | 0% | 0% | 0% | 0% |
| Dept financing | 50% | 20% | 14% | 24% |
| Current Ratio | 11.44% | 1.34% | 1.11% | 0.72% |
| Quick Ratio | 0% | 1.05% | 0.86% | 0.6% |
| Cash Position Ratio | 11.19% | 0.14% | 0.46% | 0.15% |
| Liquididy | 50% | 28% | 24% | 16% |